C0162969||chitosan
C0813622||hyaluronan
C1709148||lipid nanoparticles
C0565867||delivery
C0144576||paclitaxel
C2603343||proof-of-concept study
C1512505||breast cancer cells
C1709148||solid lipid nanoparticles
C1709148||solid lipid nanoparticles
C0144576||paclitaxel
C0144576||paclitaxel
C3898158||SLN loaded with PAX
C3828864||high-pressure hot homogenization
C0524527||Formulation parameters
C0085104||high-quality delivery system
C1709148||solid lipid nanoparticles
C0162969||chitosan
C0813622||hyaluronan
C0813622||hyaluronan
C0813622||hyaluronan
C0597357||receptors
C1512505||breast cancer cell line
C0596890||MCF-7
C0162969||chitosan
C0813622||hyaluronan
C1709148||solid lipid nanoparticles
C3888108||cellular uptake
C0144576||paclitaxel
C1709148||solid lipid nanoparticles
C1706209||carrier candidates
C0278627||nano-oncology
C0304497||cytotoxic potential
C0243095||overcoming
C0282588||multidrug-resistant cancer cells